Related Experiment Video
Updated: Aug 18, 2026

A Tandem Liquid Chromatography–Mass Spectrometry-based Approach for Metabolite Analysis of Staphylococcus aureus
Published on: March 28, 2017
"Streptomyces avermitilis" mutants defective in methylation of avermectins
Abstract:
"Streptomyces avermitilis" mutants defective in the methylation of the avermectins have been isolated and characterized. Four mutant strains, CR-1, CR-2, CR-3, and CR-4, were unable to methylate the oxygen at C5 of the macrolide moiety and produced essentially only the avermectin B components. These four strains lack avermectin B2 O-methyltransferase (B2OMT) activity. Two mutant strains were unable to methylate the oleandrose moiety at the oxygens at C3' and C3'' and produced essentially only demethylavermectin components. One of these mutants, strain CR-5 (derived from wild-type "S. avermitilis"), produced demethylavermectin A and B components and possessed normal B2OMT levels. The other mutant, strain CR-6 (derived from strain CR-1, which lacks B2OMT activity), produced only demethylavermectin B components. Reaction of 3"-O-demethylavermectin B2a and S-adenosylmethionine with either cell extracts or purified B2OMT resulted in the methylation of the oxygen at C5 of the macrolide moiety and yielded only 3''-O-demethylavermectin A2a as the product. These experiments indicate that different enzymes are required for methylation of the macrolide (the oxygen at C5) and the oleandrose (oxygen at C3) and that methylation of the oleandrose occurs before attachment to the macrolide ring.
Insights
Mutants of Streptomyces avermitilis were studied for avermectin methylation defects. Two distinct enzymes are responsible for methylating the macrolide and oleandrose moieties, with oleandrose methylation occurring first.
Area of Science:
- Microbial biochemistry
- Natural product biosynthesis
- Enzymology
Background:
- Avermectins are potent antiparasitic compounds produced by Streptomyces avermitilis.
- Post-biosynthetic modifications, such as methylation, are crucial for avermectin activity.
- Understanding the enzymatic pathways involved in avermectin modification is essential for metabolic engineering and drug discovery.
Purpose of the Study:
- To identify and characterize Streptomyces avermitilis mutants with defects in avermectin methylation.
- To elucidate the specific enzymatic steps and the order of methylation reactions in avermectin biosynthesis.
- To differentiate the enzymes responsible for methylating the macrolide and oleandrose moieties.
Main Methods:
- Isolation and characterization of spontaneous mutants of Streptomyces avermitilis.
- Analysis of avermectin components produced by mutant strains using chromatographic techniques.
- Enzyme assays to determine avermectin B2 O-methyltransferase (B2OMT) activity in cell extracts and purified enzymes.
- In vitro methylation reactions using demethylated avermectin precursors and S-adenosylmethionine.
Main Results:
- Four mutants (CR-1 to CR-4) lacked avermectin B2 O-methyltransferase (B2OMT) activity, indicating impaired methylation at the C5 oxygen of the macrolide moiety, producing only avermectin B components.
- Two mutants (CR-5 and CR-6) showed defects in methylating the oleandrose moiety at C3' and C3'', producing demethylavermectin components.
- In vitro studies confirmed that distinct enzymes methylate the macrolide (C5 oxygen) and the oleandrose (C3 oxygen), with oleandrose methylation preceding macrolide attachment.
Conclusions:
- Two separate enzymatic activities are responsible for the methylation of the macrolide and oleandrose sugar moieties of avermectins.
- The methylation of the oleandrose moiety occurs prior to its attachment to the macrolide ring structure.
- These findings provide critical insights into the avermectin biosynthetic pathway, enabling targeted manipulation for novel avermectin derivatives.
Related Concept Videos
Mismatch Repair
Inhibitors of Bacterial Protein Synthesis

